tbuckley/cabot-search huggingface dataset:
Oral Semaglutide and Cardiovascular Outcomes in Persons With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial
Authors: Nikolaus Marx, John E. Deanfield, Johannes F.E. Mann, Rosario Arechavaleta, Stephen C. Bain, Harpreet S. Bajaj, Katrine Bayer Tanggaard, Andreas L. Birkenfeld, John B. Buse, Zaklina Davicevic-Elez, Cyrus Desouza, Scott S. Emerson, Mads D.M. Engelmann, G. Kees Hovingh, Silvio E. Inzucchi, Pardeep S. Jhund, Sharon L. Mulvagh, Rodica Pop-Busui, Neil R. Poulter, Søren Rasmussen, Shih-Te Tu, Darren K. McGuire
Journal: Circulation (2025)

Both glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose co-transporter-2 inhibitors (SGLT2i) improve cardiovascular (CV) outcomes in people with type 2 diabetes (T2D) and CV or chronic kidney disease (CKD). However, there are limited data about the effect of combining these agents on CV and safety outcomes. The SOUL trial (NCT03914326) randomised 9650 participants with T2D and atherosclerotic CV disease and/or CKD to oral semaglutide or placebo. As prespecified, participants were analysed according to baseline use of SGLT2i (Yes: n=2596, No: n=7054) and, subsequently for any use of SGLT2i during the trial (Yes: n=4718, No: n=4932). The primary outcome was time to first major adverse cardiovascular event (MACE), defined as cardiovascular death, non-fatal myocardial infarction or non-fatal stroke. Safety was evaluated by comparing the incidence of serious adverse events. Over a mean follow-up of 47.5±10.9 months, the risk of the primary outcome in the overall trial population was 14% lower for oral semaglutide vs placebo (hazard ratio [HR] 0.86, 95% confidence interval [CI] 0.77; 0.96). In those taking SGLT2i at baseline, there were 143/1296 (semaglutide) versus 158/1300 (placebo) primary outcome events (HR 0.89; 95% CI 0.71; 1.11); and 436/3529 versus 510/3525, respectively, in participants not taking SGLT2i at baseline (HR 0.84; 95% CI 0.74; 0.95; P-interaction 0.66). An analysis of MACE by any in-trial SGLT2i use versus no use also showed no evidence of heterogeneity in the effects of oral semaglutide. The adverse event profiles of oral semaglutide with or without concomitant SGLT2i were similar. Oral semaglutide reduced MACE outcomes independently of concomitant SGLT2i treatment and this combination appeared to be safe.
CONTINUED VERSUS INTERRUPTED ORAL ANTICOAGULATION DURING TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH ATRIAL FIBRILLATION: A META-ANALYSIS
Authors: Hritvik Jain, NANDAN PATEL, JYOTI JAIN, Khadija Amanullah, Amanpreet Singh Wasir, Mushood Ahmed, Faizan Ahmed, Ali Saad Al-Shammari, Raheel Ahmed, Rozi Khan, Pooja Sethi, Thomas Alexander
Journal: Journal of the American College of Cardiology (2025)
SAFETY AND EFFICACY OF IVABRADINE IN THE TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: A REAL-WORLD PROPENSITY SCORE MATCHING STUDY
Authors: Tianshu Gu, Yukun Zhang, Sutao Hu, Jingkun Zhang, Xue Wu, Xing Liu, Xian Shao, LIN WANG, Jinhua Zhao, Tong Liu, KangYin Chen
Journal: Journal of the American College of Cardiology (2025)
PRE-PROCEDURAL FASTING IN PERCUTANEOUS CARDIAC PROCEDURES: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS
Authors: Mangesh Kritya, Priyanshi Maurya, Shanmukh Sai Pavan Lingamsetty, Hritvik Jain, Eeshal Zulfiqar, Muhammad Daoud Tariq, Mohamed Doma, Iuri Ferreira Felix
Journal: Journal of the American College of Cardiology (2025)
LONG-TERM CLINICAL OUTCOMES OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR USE IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS SURGERY
Authors: Osamah Badwan, Akiva Rosenzveig, Habib Layoun, Saeid Mirzai, Ahmad Safdar, Michael Anthony Militello, Faisal Bakaeen, Dennis Bruemmer
Journal: Journal of the American College of Cardiology (2025)
A SYSTEMATIC REVIEW AND META-ANALYSIS OF INTERMITTENT FASTING VERSUS CONTINUOUS CALORIC RESTRICTION ON CARDIOMETABOLIC OUTCOMES IN CORONARY ARTERY DISEASE PATIENTS
Authors: Shahnawaz Notta, Nasir Notta, Mohannad Al Akeel, Ashwin Jagadish, Mohammad Al-Dqour, Manar H. Jbara, Vijay K. Ramu
Journal: Journal of the American College of Cardiology (2025)
SAFETY AND EFFICACY OF PERCUTANEOUS TRANSCATHETER EDGE-TO-EDGE MITRAL VALVE REPAIR FOR FUNCTIONAL MITRAL REGURGITATION IN HEART FAILURE: A META-ANALYSIS
Authors: Hritvik Jain, NANDAN PATEL, JYOTI JAIN, Khadija Amanullah, Mushood Ahmed, Aman Goyal, Faizan Ahmed, Mubaraka Amanullah, Raheel Ahmed, Rozi Khan, Pooja Sethi, Thomas Alexander
Journal: Journal of the American College of Cardiology (2025)
PREDICTORS OF LUMINAL GAIN AFTER CORONARY LITHOTRIPSY: INSIGHTS FROM AN INTERNATIONAL, MULTICENTER, REAL-WORLD, ALL-COMERS REGISTRY
Authors: Martijn Van Oort, Federico Oliveri, Ibtihal Al Amri, Bimmer E. Claessen, Aukelien Dimitriu-Leen, Joelle Kefer, hany girgis, Frank Van Der Kley, Johan Wouter Jukema, Jose Manuel Montero Cabezas
Journal: Journal of the American College of Cardiology (2025)
THE EFFICACY OF 15MG OF EDOXABAN ON LONG-TERM OUTCOME AFTER PCI IN PATIENTS WITH ATRIAL FIBRILLATION AND HIGH BLEEDING RISK
Authors: Takao Sato, Yusuke Matsumoto, Kazuho Ishii, Takahiko Kiyooka, Yoshifusa Aizawa
Journal: Journal of the American College of Cardiology (2025)
SHORT AND LONG-TERM OUTCOMES IN PATIENTS WITH AUTOIMMUNE DISEASES UNDERGOING TRANSCATHETER EDGE TO EDGE REPAIR: A PROPENSITY MATCHED COHORT STUDY
Authors: Louie Kamel-Abusalha, Alan Fahoury, Alexander J. Didier, Shazil Mahmood, Fouad Bouso, Omar Zayed, Andrew Treihaft, Mohamad Alghothani
Journal: Journal of the American College of Cardiology (2025)
IMPACT OF TAFAMIDIS ON HEART FAILURE OUTCOMES IN TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: A RETROSPECTIVE ANALYSIS
Authors: Shahnawaz Notta, Nasir Notta, Mohannad Al Akeel, Ashwin Jagadish, Mohammad Al-Dqour, Manar H. Jbara, Vijay K. Ramu
Journal: Journal of the American College of Cardiology (2025)
TRANSCATHETER EDGE-TO-EDGE MITRAL VALVE REPAIR IN PATIENTS WITH SEVERE LEFT VENTRICULAR DILATATION
Authors: Roy Raphael, Paul Fefer, Elad Maor, Adi Butnaru, Kobi Faierstein, Rafael Kuperstein, Noam Makmal, Rotem Tal-Ben Ishay
Journal: Journal of the American College of Cardiology (2025)
VALIDATING THE USE OF MEDICARE CLAIMS DATA TO EVALUATE COVARIATES &amp; OUTCOMES AMONG MEDICARE ADVANTAGE PATIENTS ENROLLED IN THE EVOLUT LOW-RISK TRIAL
Authors: Christina Lalani, Frank A. Medina, Lichen Liang, Yang Song, Neel Butala, Jordan B. Strom, Robert W. Yeh
Journal: Journal of the American College of Cardiology (2025)
OUTCOMES OF TRANSCATHETER AORTIC VALVE REPLACEMENT PERFORMED WITHIN 90 DAYS AFTER ACUTE MYOCARDIAL INFARCTION: A NATIONWIDE ANALYSIS
Authors: Ahmed M. Younes, Ibrahim Kamel, Ahmed K. Mahmoud, Mahmoud Khalil, Ahmed M. Maraey, Ahmed Elzanaty, Hadeer Rafat Elsharnoby, Islam Elgendy
Journal: Journal of the American College of Cardiology (2025)
SGLT2 INHIBITORS DELAY PROGRESSION OF CAROTID PLAQUE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A RETROSPECTIVE COHORT STUDY
Authors: Qiao-Qing Zhong, Paul Ambarus, Yuhan Yang, Yifan Bu, Adil Al-Karim Manji, Usman Ahmed, Feroze Mahmood, Robina Matyal
Journal: Journal of the American College of Cardiology (2025)
IN-HOSPITAL OUTCOMES AND READMISSIONS FOLLOWING TRANSCATHETER MITRAL VALVE INTERVENTIONS IN OCTOGENARIANS AND NONAGENARIANS
Authors: Mahmoud Ismayl, Hasaan Ahmed, Andrew Michael Goldsweig, Mackram F. Eleid, Charanjit S. Rihal, Mayra E. Guerrero
Journal: Journal of the American College of Cardiology (2025)
PREDICTORS OF UPPER GASTROINTESTINAL BLEEDING IN PATIENTS ADMITTED FOR LEFT ATRIAL APPENDAGE OCCLUSION AND IMPACT ON MORTALITY
Authors: Renuka Verma, Parampreet Johal, Kanwar Bir Singh Dhaliwal, RUTVI HITESHKUMAR AMIN, Gagandeep Singh Arora, Rahul Singla, Hemamalini Sakthivel, Kamleshun Ramphul, Nomesh Kumar, Jasninder Singh Dhaliwal
Journal: Journal of the American College of Cardiology (2025)
THE PROGNOSTIC VALUE OF NEUTROPHIL TO LEUKOCYTE RATIO IN RISK STRATIFICATION AND OUTCOMES OF TRANSCATHETER AORTIC VALVE REPLACEMENT: A SYSTEMATIC REVIEW
Authors: Vagisha Sharma, Harendra Kumar, Prima Wulandari, Akriti Agarwal, Adishwar Rao, Anubhuti Sharma, Saurabh Sharma
Journal: Journal of the American College of Cardiology (2025)
CONSERVATIVE APPROACH VERSUS PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH SPONTANEOUS CORONARY ARTERY DISSECTION FROM A NATIONAL POPULATION-BASED COHORT STUDY
Authors: Beatriz Castillo Rodriguez, Song Peng Ang, Yusuf K. Qadeer, Zhen Wang, Mahboob Alam, Samin K. Sharma, Hani Jneid, Chayakrit Krittanawong
Journal: Journal of the American College of Cardiology (2025)
OUTCOMES AFTER CORONARY ARTERY BYPASS GRAFT VERSUS PERCUTANEOUS CORONARY INTERVENTION WITH OR WITHOUT INTRACORONARY IMAGING IN PATIENTS WITH MULTI-VESSEL CORONARY ARTERY DISEASE
Authors: Macy Meyer, Talia Meidan, Jordan Kuhlman, Ghadi Moubarak, Andrew Wu, Luke Frizzell, Kendall Hammonds, Jose E. Exaire, Timothy A. Mixon, Karim Al-Azizi, Molly Szerlip, Robert Jay Widmer
Journal: Journal of the American College of Cardiology (2025)
CLINICAL OUTCOMES WITH DEXMEDETOMIDINE IN AORTIC VASCULAR INTERVENTIONS: A METAANALYSIS
Authors: Tallal Mushtaq Hashmi, Hadiah Ashraf, Rohma Zia, Muhammad Burhan, Mushood Ahmed, Faizan Ahmed, Muhammad Burhan, Nitish Behary Paray, Caleb Carver, Muhammad Abdullah Naveed, Muzammil Farhan, Mohsin Zia Sana Ullah, Hritvik Jain, Raheel Ahmed, Farhan Shahid, Sohail Q. Khan, Majid Toseef Aized
Journal: Journal of the American College of Cardiology (2025)
EFFECTS OF PERCUTANEOUS CORONARY INTERVENTION AND INTRA-AORTIC BALLOON SUPPORT ON 30-DAY SURVIVAL AND HEART FAILURE READMISSIONS IN A LARGE SAFETY-NET HOSPITAL
Authors: Stephanie E. Jinno, Tejal Ghadiali, Pratik P. Doshi, Anushka Das, Michael Fong
Journal: Journal of the American College of Cardiology (2025)
TOTAL ISCHEMIC TIME AS A PREDICTOR OF MICRO-VASCULAR DYSFUNCTION IN STEMI PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTIONS (PPCI): INSIGHTS INTO SLOW-FLOW/NO-REFLOW PHENOMENON
Authors: Syeda Kahkashan Zehra, Shakir Zada, Naveed Ullah Khan, Haroon Ishaq, Paras Nazir Kalwar, Shueeta Kumari, Salman Khan, Ejaz Ul Haq, ABDUL HAMEED, Poonam Bai
Journal: Journal of the American College of Cardiology (2025)
COMPARISON OF SURGICAL OUTCOMES BETWEEN CAROTID ENDARTERECTOMY (CEA) ANDTRANSCAROTIDARTERY REVASCULARIZATION (TCAR) PROCEDURE
Authors: Ali Mohsin Choudhry, Kathleen Mattingly, Connor M. Petrovich, Mahmoud Hazim, Adesh Prashad, Rakesh Prashad
Journal: Journal of the American College of Cardiology (2025)
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
Authors: Darren K McGuire, Nikolaus Marx, Sharon L Mulvagh, John E Deanfield, Silvio E Inzucchi, Rodica Pop-Busui, Johannes F E Mann, Scott S Emerson, Neil R Poulter, Mads D M Engelmann, Maria Sejersten Ripa, G Kees Hovingh, Kirstine Brown-Frandsen, Stephen C Bain, Matthew A Cavender, Mette Gislum, Jens-Peter David, John B Buse
Journal: New England Journal of Medicine (2025)

The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the cardiovascular efficacy of oral semaglutide in persons with type 2 diabetes and atherosclerotic cardiovascular disease, chronic kidney disease, or both is needed. In this double-blind, placebo-controlled, event-driven, superiority trial, we randomly assigned participants who were 50 years of age or older, had type 2 diabetes with a glycated hemoglobin level of 6.5 to 10.0%, and had known atherosclerotic cardiovascular disease, chronic kidney disease, or both to receive either once-daily oral semaglutide (maximal dose, 14 mg) or placebo, in addition to standard care. The primary outcome was major adverse cardiovascular events (a composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke), assessed in a time-to-first-event analysis. The confirmatory secondary outcomes included major kidney disease events (a five-point composite outcome). Among the 9650 participants who had undergone randomization, the mean (±SD) follow-up was 47.5±10.9 months, and the median follow-up was 49.5 months. A primary-outcome event occurred in 579 of the 4825 participants (12.0%; incidence, 3.1 events per 100 person-years) in the oral semaglutide group, as compared with 668 of the 4825 participants (13.8%; incidence, 3.7 events per 100 person-years) in the placebo group (hazard ratio, 0.86; 95% confidence interval, 0.77 to 0.96; P = 0.006). The results for the confirmatory secondary outcomes did not differ significantly between the two groups. The incidence of serious adverse events was 47.9% in the oral semaglutide group and 50.3% in the placebo group; the incidence of gastrointestinal disorders was 5.0% and 4.4%, respectively. Among persons with type 2 diabetes and atherosclerotic cardiovascular disease, chronic kidney disease, or both, the use of oral semaglutide was associated with a significantly lower risk of major adverse cardiovascular events than placebo, without an increase in the incidence of serious adverse events. (Funded by Novo Nordisk; SOUL ClinicalTrials.gov number, NCT03914326.).
REDO SURGICAL AORTIC VALVE REPLACEMENT (SAVR) VS. VALVE-IN-VALVE TRANSCATHETER AORTIC VALVE IMPLANTATION (VIV-TAVI) FOR PATIENTS AS A TREATMENT FOR DEGENERATIVE VALVES, A SYSTEMATIC REVIEW AND META-ANALYSIS
Authors: Ali Moradi, Pouya Ebrahimi, Maryam Taheri, Hamidreza Soleimani, Homa Taheri, Babak Sattartabar, Morvarid Taebi, Iman Bhia, Mehrdad Mahalleh, Mohsen Anafje, Masih Tajdini, Islam Elgendy, Kaveh Hosseini, Robert J. Siegel
Journal: Journal of the American College of Cardiology (2025)
SAFETY AND EFFICACY OF PARAVALVULAR LEAK CLOSURE IN POST TAVR PATIENTS: A SINGLECENTER EXPERIENCE
Authors: Omar Sami Abdelhai, Mustafa Mohammed, Tiberio M. Frisoli, James Chihong Lee, William W. O’Neill, Bryan Zweig, Brian Patrick O’Neill, John Dawdy, Pedro Engel Gonzalez, Pedro Arturo Villablanca
Journal: Journal of the American College of Cardiology (2025)
ONE MONTH AND ONE YEAR HEMODYNAMIC COMPARISONS OF THE 5TH GENERATION EDWARDS SAPIEN 3 ULTRA RESILIA COMPARED TO SAPIEN 3 AND SAPIEN 3 ULTRA FOR TRANSCATHETER AORTIC VALVE REPLACEMENTS; A SINGLE-CENTER STUDY
Authors: Nicholas Wenz, Konner Feldhus, Mitchell Kerr, Veronica Graham, Gerard Salame, Jake Michael Chanin
Journal: Journal of the American College of Cardiology (2025)
CLINICAL OUTCOMES AND 30-DAY READMISSION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH HISTORY OF OBESITY AND PRIOR BARIATRIC SURGERY: A NATIONAL ANALYSIS
Authors: Nameer E. Ascandar, Joseph Hadaya, Alice Boican, Sabry Omar, Michael Schandorf-Lartey, Peyman Benharash
Journal: Journal of the American College of Cardiology (2025)
PREVALENCE AND PROGNOSTIC IMPACT OF HIGH ISCHEMIC RISK CRITERIA IN CHRONIC CORONARY SYNDROME PATIENTS UNDERGOING PCI
Authors: Mauro Gitto, Samantha Sartori, Birgit Vogel, Iva Srdanovic, Angelo Oliva, Yihan Feng, Prakash Krishnan, Benjamin Bay, Joseph Michael Sweeny, Francesca Maria Di Muro, Johny Nicolas, Pedro R. Moreno, Pooja Vijay, Roja Thapi, Annapoorna Subhash Kini, George D. Dangas, Samin K. Sharma, Roxana Mehran
Journal: Journal of the American College of Cardiology (2025)
ANTIPLATELET DE-ESCALATION STRATEGY AFTER PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Authors: Mushood Ahmed, Areeba Ahsan, Priyansha Singh, Aimen Shafiq, Nitish Behary Paray, Caleb Carver, Syed Khurram Mushtaq Gardezi, Irfan Ullah, Syed Tabeer Hussain Naqvi, Amaad Shah, Ali Hasan, Hasan Ahmad, Faizan Ahmed, Muhammad Abdullah Naveed, Hritvik Jain, Raheel Ahmed, Farhan Shahid, Sohail Q. Khan
Journal: Journal of the American College of Cardiology (2025)
BIVALIRUDIN VERSUS HEPARIN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN ACUTE CORONARY SYNDROMES
Authors: Yusuf K. Qadeer, Chayakrit Krittanawong, Zhen Wang, Tania Ahuja, Mahboob Alam, Hani Jneid
Journal: Journal of the American College of Cardiology (2025)
Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials
Authors: Matthew M.Y. Lee, Naveed Sattar, Rodica Pop-Busui, John Deanfield, Scott S. Emerson, Silvio E. Inzucchi, Johannes F.E. Mann, Nikolaus Marx, Sharon L. Mulvagh, Neil R. Poulter, Sunil V. Badve, Richard E. Pratley, Vlado Perkovic, John B. Buse, Darren K. McGuire
Journal: Diabetes Care (2025)

Glucagon-like peptide 1 receptor agonists (GLP-1RA) reduce the incidence of major adverse cardiovascular events (MACE) in type 2 diabetes (T2D), although whether benefits extend to both subcutaneous and oral formulations remains unclear. In these meta-analyses, including new data from the Semaglutide cardiOvascular oUtcomes triaL (SOUL) (oral semaglutide) and Evaluate Renal Function with Semaglutide Once Weekly (FLOW) trial, we examined cardiovascular (CV) and kidney benefits and risks of long-acting (defined as having pharmacokinetics sufficient to provide 24-h activity) GLP-1RA in T2D. A systematic review of PubMed was conducted (to 7 February 2025). Randomized placebo-controlled CV and kidney outcomes trials of GLP-1RA with ≥500 individuals with T2D were included. A random-effects model was used to estimate hazard ratios (HRs) for MACE, its components, all-cause mortality, hospitalization for heart failure (HHF), a composite kidney outcome (kidney failure [kidney replacement therapy or persistent estimated glomerular filtration rate [eGFR] <15 mL/min/1.73 m2], sustained ≥50% eGFR decline or nearest equivalent, or kidney-related death), worsening kidney function, and safety outcomes. Across 10 trials (n = 71,351), long-acting GLP-1RA reduced incidence rate of MACE by 14% (HR 0.86 [95% CI 0.81, 0.90]; I2 = 27.6%), HHF by 14% (0.86 [0.79, 0.93]; I2 = 2.1%), and the composite kidney outcome by 17% (0.83 [0.75, 0.92]; I2 = 20.4%) and all-cause mortality by 12% (0.88 [0.82, 0.93]; I2 = 17.5%). A consistent 14% reduction was seen for all MACE components. There was no significant heterogeneity by GLP-1RA administration route (subcutaneous vs. oral). There were no increased risks of severe hypoglycemia, retinopathy, or pancreatic events. Trial-level meta-analyses preclude detailed subgroup analyses and may introduce ecological bias. As a group, long-acting GLP-1RA, including both injectable and oral formulations, reduce incidence of MACE, HHF, and kidney events and all-cause mortality in T2D.
ANTITHROMBOTIC THERAPY AND OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Authors: Sahand Siami, Saba Maleki, Sina Kazemian, elham ebrahimi, Mandana Ebrahimzade, Fatemeh Jodeiri, Mohsen Hajiqasemi, Sara Ebrahimi, Maede Mehdizadeh, Mona Aghaei, Mohammad-Mahdi Bastan, Mehrshad Fathian Sabet, Roozbeh Nazari, Pouya Ebrahimi, Jamal S. Rana, Michael Nanna, Jay S. Giri, Dhaval Kolte, Mohamad Adnan Alkhouli, Kaveh Hosseini
Journal: Journal of the American College of Cardiology (2025)
CLINICAL OUTCOMES AND PATENCY OF STENT-GRAFT IMPLANTED IN COMMON FEMORAL ARTERY DUE TO TAVR ACCESSES SITE COMPLICATION
Authors: Zvonimir Ostojic, Luka Percin, Antonio Hanzek, Hrvoje Jurin, Tomislav Krcmar, Josko Bulum
Journal: Journal of the American College of Cardiology (2025)
CATHETER-BASED VS. ULTRASOUND-BASED RENAL DENERVATION FOR THE TREATMENT OF HYPERTENSION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Authors: Saeed Shoar, Ashok Chaudhary, Samin K. Sharma, Manish Vinayak, Suman Pasupuleti, Nishant Nerella, Serdar Farhan
Journal: Journal of the American College of Cardiology (2025)
REGRESSION OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH PARADOXICAL LOW FLOW, LOW GRADIENT AORTIC STENOSIS TREATED WITH TRANSCATHETER AORTIC VALVE REPLACEMENT
Authors: Khagendra Dahal, Aiden Gravina, Talhat Azemi, Immad Sadiq, Mohiuddin Cheema, Sean Robert McMahon, Vincent Lipari, William Lane Duvall, Nicole Hoover, Jeffrey F. Mather, Raymond McKay
Journal: Journal of the American College of Cardiology (2025)
COMMON HEPATIC AND BILATERAL RENAL ARTERY DENERVATION USING A MULTIELECTRODE RADIOFREQUENCY CATHETER SYSTEM REDUCES TISSUE NOREPINEPHRINE IN A NORMOTENSIVE PORCINE MODEL
Authors: Felix Mahfoud, Stefan Tunev, David E. Kandzari, Eric Alexander Secemsky, Pam Taub, Raven Voora, Julie Trudel, Douglas A. Hettrick
Journal: Journal of the American College of Cardiology (2025)
IMPACT OF FASTING VS NON-FASTING PRIOR TO CORONARY INTERVENTIONS ON PATIENT OUTCOMES AND SATISFACTION: A SYSTEMATIC REVIEW AND META- ANALYSIS
Authors: Arya Kulkarni, Amanpreet Singh Wasir, Aditi Kumar, Ashvath Pillai, Aishwarya J, Naveen Goyal
Journal: Journal of the American College of Cardiology (2025)
AORTIC VALVE CALCIFICATION AS A PREDICTOR OF TRANSCATHETER AORTIC VALVE REPLACEMENT OUTCOMES ACROSS THE SPECTRUM OF LOW-FLOW, LOW-GRADIENT AORTIC STENOSIS
Authors: Yash Prakash, Lakshay Chopra, Akarsh Sharma, Ranbir Singh, Ankur Dalsania, Francesca Romana Prandi, Joseph Maenza, Eileen Galvani, Thomas Hanlon, Gilbert Hin-Lung Tang, George D. Dangas, Sahil Khera, Annapoorna Subhash Kini, Samin K. Sharma, Stamatios Lerakis
Journal: Journal of the American College of Cardiology (2025)
CLINICAL OUTCOMES OF THE FIRST 200 CASES OF SINGLE-OPERATOR TEE-GUIDED LEFT ATRIAL APPENDAGE OCCLUSION (SOLO-CLOSE)
Authors: Hafez Golzarian, Mallory Knous, Anna Kleman, Gerri Lynn Hempfling, Sandeep Mahlesh Patel
Journal: Journal of the American College of Cardiology (2025)
TICAGRELOR MONOTHERAPY AFTER 1-MONTH DUAL ANTIPLATELET THERAPY VERSUS STANDARD DUAL ANTIPLATELET THERAPY FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Authors: Hashim Mohamed Siraj, Nivedita Pant, sakshi bidkar, Gyanendra Jora, Mohamed Elgebaly, Arwa Ibrahim, FNU Sadia, Sanaf Nisar Hamdulay, Adeeb Ali Mohammad, Ayra Maqbool, Ayesha Iqbal Mansoor, Onyekachi Emmanuel Anyagwa
Journal: Journal of the American College of Cardiology (2025)
ASPIRIN DISCONTINUATION WITHIN 1 MONTH VS AT 3 MONTHS WITH TICAGRELOR MONOTHERAPY IN ACUTE CORONARY SYNDROME: AN INDIVIDUAL PATIENT DATA POOLED ANALYSIS OF TICO AND T-PASS TRIALS
Authors: Jung-Hee Lee, Jun-Won Lee, Young Jin Youn, Sung Gyun Ahn, Yong-Joon Lee, Seung-Jun Lee, Sung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong
Journal: Journal of the American College of Cardiology (2025)
HEART TRANSPLANTATION IS ASSOCIATED WITH IMPROVED SURVIVAL IN POST-MYOCARDIAL INFARCTIONVENTRICULAR SEPTAL RUPTURE: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE DATABASE
Authors: Daniel Hanna, Dhiran Verghese, Juan Sierra David, Wael Dakkak, Brian Solomon, Travis Howard, Luis H. Paz Rios, Mazen Albaghdadi, Roberto J. Cubeddu
Journal: Journal of the American College of Cardiology (2025)
TRANSCATHETER PULMONARY VALVE REPLACEMENT OR REPAIR HAS BETTER IN-HOSPITAL OUTCOMES COMPARED TO SURGERY: A NATIONWIDE STUDY
Authors: Mohammad Ali Sheffeh, Omar J. Baqal, Dua A. Malik, Judy Sheffeh, Jacob Klein, Ider Oujamaa, Mustafa Turkmani, M. Chadi Alraies
Journal: Journal of the American College of Cardiology (2025)
DISPARITIES IN MORTALITY AND RESOURCE UTILIZATION FOR ACUTE CORONARY SYNDROME WITH MECHANICAL SUPPORT DEVICES: A COMPARATIVE ANALYSIS OF WEEKEND VS. WEEKDAY ADMISSIONS USING NATIONAL INPATIENT DATA
Authors: Godbless Ebruvwiyor Ajenaghughrure, Karldon Nwaezeapu, Mohammed Najdat Seijari, God-dowell O. Odukudu, Emmanuel O. Daniel, oluchi Ndulue, M Kenan Rahima, Pranita Rajbhandari, Gehna Kishore, Oboseh John Ogedegbe, Nadim Jaafar
Journal: Journal of the American College of Cardiology (2025)
IMPACT OF BASELINE THROMBOCYTOPENIA ON ISCHEMIC, BLEEDING, AND MORTALITY RISK AFTER PERCUTANEOUS CORONARY INTERVENTION
Authors: Tushar Mishra, Angelo Oliva, Yash Prakash, Francesca Maria Di Muro, Samantha Sartori, Yihan Feng, Serdar Farhan, Roxana Mehran, Annapoorna Subhash Kini, Samin K. Sharma
Journal: Journal of the American College of Cardiology (2025)
SEX DISPARITIES IN THE OUTCOMES OF MYOCARDIAL INFARCTION WITH NONOBSTRUCTIVE CORONARY ARTERIES: A PROPENSITY-SCORE MATCHED NATIONWIDE ANALYSIS
Authors: Paawanjot Kaur, Abdul Rasheed Bahar, Yasemin Bahar, Mohamed S. Alrayyashi, Yousef Alsmairat, Abdalaziz Awadelkarim, M. Chadi Alraies
Journal: Journal of the American College of Cardiology (2025)